PHAZYME is a Oral Tablet, Chewable in the Human Otc Drug category. It is labeled and distributed by C.b. Fleet Company, Inc.. The primary component is Calcium Carbonate; Dimethicone.
| Product ID | 0132-0507_428c1326-85da-4bc5-a2ae-1f7e10e31ef0 |
| NDC | 0132-0507 |
| Product Type | Human Otc Drug |
| Proprietary Name | PHAZYME |
| Generic Name | Simethicone And Calcium Carbonate |
| Dosage Form | Tablet, Chewable |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-03-01 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part332 |
| Labeler Name | C.B. Fleet Company, Inc. |
| Substance Name | CALCIUM CARBONATE; DIMETHICONE |
| Active Ingredient Strength | 750 mg/241; mg/241 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part332 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-03-01 |
| Ingredient | Strength |
|---|---|
| CALCIUM CARBONATE | 750 mg/241 |
| SPL SET ID: | 848d7c23-a12b-49c4-8fda-da15efca33ad |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0132-0208 | PHAZYME | Simethicone |
| 0132-0211 | PHAZYME | Simethicone |
| 0132-0214 | PHAZYME | Simethicone |
| 0132-0215 | PHAZYME | Simethicone |
| 0132-0507 | PHAZYME | Simethicone and Calcium Carbonate |
| 63029-550 | PHAZYME | Simethicone |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PHAZYME 86021791 4585881 Live/Registered |
C.B. Fleet Company, Incorporated 2013-07-28 |
![]() PHAZYME 78192505 2855210 Live/Registered |
C.B. FLEET COMPANY, INC. 2002-12-09 |
![]() PHAZYME 78192497 2867909 Live/Registered |
C.B. FLEET COMPANY, INC. 2002-12-09 |
![]() PHAZYME 72116259 0722166 Live/Registered |
Reed & Carnrick 1961-03-22 |